Effect of herbal cream containing Fumaria officinalis and silymarin for treatment of eczema: A randomized double-blind controlled clinical trial

Document Type : Original Research Article


1 Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

2 Department of Pharmaceutics, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

3 Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

4 Medicinal Plant Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran


Objective: Atopic dermatitis (AD) is a common skin disorder with symptoms including severe pruritus and eczematous lesions. AD affects between 5 and 20% of people in their life. Silymarin (SM) is a polyphenolic flavonoid from Silybum marianum L.  and has several therapeutic characteristics including antiallergic, anticancer, and anti-inflammatory properties. Fumaria officinalis is a small plant that has a high antioxidant power and modulating effects on the immune system. Therefore, the current study intended to examine the influence of these two herbs extract on severity and symptoms of AD in patients.
Materials and Methods: 40 patients with mild to moderate eczema randomly received mometasone 0.1% or the herbal cream. Treatment course was 2 weeks and patients were examined before and after 2 weeks of treatment using the SCORAD system.
Results: The reduction of SCORAD score was significant in both groups (p=0.04 in the herbal group and p=0.03 in the mometasone group) but no significant difference was observed between the groups. Mean SCORAD score was 27.66±5.9 before therapy and 4.77±1.6 after therapy in the mometasone group and mean SCORAD score was 26.05±7.1 before therapy and 6.944±2.6 after therapy in the herbal group.
Conclusion: The current study indicated the impact of these two herbs extract on severity and symptoms of AD in patients; these plants may be a new treatment in reducing eczema symptoms and its problems.


Adham AN, Naqishbandi AM, Efferth T. 2021.
Cytotoxicity and apoptosis induction by
Fumaria officinalis extracts in leukemia and
multiple myeloma cell lines. J
Ethnopharmacol, 10: 113458.
Ashtiani HRA, Dadgar A, Akaberi M. 2020.
Improvement of cell proliferation and
antioxidant activity of silymarin in hair
follicles dermal papillae isolated from the
human scalp: comparison with vitamin C
effects. Int J Trichology, 12: 168-175.
Banafsche R, Gunther L, Nefflen JU, Moutsiou
S, Knolle PA, Herfarth C, Klar E. 2001. NFkappa B antisense oligonucleotides reduce
leukocyteendothelial interaction in hepatic
ischemiareperfusion. Transplant Proc, 33:
Bauer A, Lange N, Matterne U, Meurer M,
Braeutigam M, Diepgen TL. 2011. Efficacy
of pimecrolimus 1% cream in the long-term
management of atopic hand dermatitis. A
double-blind RCT. J Dtsch Dermatol Ges,
10: 426-433.
Bozek A, Zajac M, Krupka M. 2020. Atopic
dermatitis and psoriasis as overlapping
syndromes. Mediators Inflamm, 2020:
Gazak R, Walterova D, Kren V. 2007. Silybin
and silymarin – new and emerging
applications in medicine. Curr Med Chem,
14: 315–338.
Hamidian G, Mirdar S, Raee P, Asghari K,
Jarrahi M. 2020. Silymarin protects the
structure of kidney in the neonatal rats
exposed to maternal cadmium toxicity: A
stereological study. Vet Res Forum, 11:
Han MH, Yoon WK, Lee H, Han SB, Lee K,
Park SK, Yang KH, Kim HM, Kang JS.
2007. Topical application of silymarin
reduces chemical-induced irritant contact
dermatitis in BALB/c mice. Int
Immunopharmacol, 7: 1651-1658.
Jowkar F, Jamshidzadeh A, Mirzadeh Yazdi A,
Pasalar M. 2011. The effects of fumaria
parviflora L extract on chronic hand eczema:
a randomized double-blind placebo
controlled clinical trial. Iran Red Crescent
Med J, 13: 824-828.
Jowkar F, Saki N, Mokhtarpour A, Reza Saki
M. 2014. Comparison of fumaric acid 5%
cream versus triamcinolone 0.1% cream in
the treatment of hand eczema. Acta Medica
Iranica, 52: 528‐531.
Kantor R, Thyssen JP, Paller AS, Silverberg JI.
2016. Atopic dermatitis, atopic eczema, or
eczema? A systematic review, metaanalysis, and recommendation for uniform
use of 'atopic dermatitis'. Allergy, 71: 1480-
Lee JH, Jo EH, Jung JY, Kim YE, Son MJ,
Kang SJ, Yang GJ, Shim YH, Park MC.
2020. Efficacy and safety of
socheongryong-tang among atopic
dermatitis patients with respiratory
disorders: A double-blinded, randomized,
placebo-controlled clinical trial. Front
Pharmacol, 11: 597885.
Litjens NH, Rademaker M, Ravensbergen B,
Thio HB, van Dissel JT, Nibbering PH.
2006. Effects of monomethylfumarate on
dendritic cell differentiation. Br J Dermatol,
154: 211-217.
Lorz LR, Kim D, Kim MY, Cho JY. 2020.
Panax ginseng-derived fraction BIOGF1K
reduces atopic dermatitis responses via
suppression of mitogen-activated protein
kinase signaling pathway. J Ginseng Res,
44: 453-460.
Lorz LR, Kim MY, Cho JY. 2020. Medicinal
potential of Panax ginseng and its
Iraji et al.
AJP, Vol. 12, No. 2, Mar-Apr 2022 162
ginsenosides in atopic dermatitis treatment.
J Ginseng Res, 44: 8-13.
Lu CW, Lin TY, Chiu KM, Lee MY, Huang JH,
Wang SJ. 2020. Silymarin inhibits
glutamate release and prevents against
kainic acid-Induced excitotoxic injury in
rats. Biomedicines, 8: 486.
Min K, Yoon WK, Kim SK, Kim BH. 2007.
Immunosuppressive effect of silibinin in
experimental autoimmune
encephalomyelitis. Arch Pharm Res, 30:
Montalvo-Jave E, Escalante-Tattersfield T,
Ortega-Salgado JA, Piña E, Geller DA.
2008. Factors in the pathophysiology of the
liver ischemia-reperfusion injury. J Surg
Res, 147: 153-159.
Oranje AP, Glazenburg EJ, Wolkerstorfer A, de
Waard-van der Spek FB. 2007. Practical
issues on interpretation of scoring atopic
dermatitis: the SCORAD index, objective
SCORAD and the three-item severity score.
Br J Dermatol, 157: 645-648.
Păltinean R, Mocan A, Vlase L, Gheldiu AM,
Crisan G, Ielciu I, Vostinaru O, Crisan O.
2017. Evaluation of polyphenolic content,
antioxidant and diuretic activities of six
fumaria species. Molecules, 22: 639.
Pickova D, Ostry V, Toman J, Malir F. 2020.
Presence of mycotoxins in milk thistle
(Silybum marianum) food supplements: A
review. Toxins (Basel), 12: 782.
Psomadakis CE, Han G. 2019. New and
emerging topical therapies for psoriasis and
atopic dermatitis. J Clin Aesthet Dermatol,
12: 28-34.
Raafat KM, El-Zahaby SA. 2020. Niosomes of
active fumaria officinalis phytochemicals:
antidiabetic, antineuropathic, antiinflammatory, and possible mechanisms of
action. Chin Med, 15: 40.
Rainone F. 2005. Milk Thistle. Am Fam
Physician, 72: 1285-1288.
Sheehan MP, Stevens H, Ostlere LS, Atherton
DJ, Brostoff J, Rustin MH. 1995. Follow-up
of adult patients with atopic eczema treated
with Chinese herbal therapy for 1 year. Clin
Exp Dermatol, 20: 136-140.
Thouvenin MD, Bacquey A, Nocera T, Rossi
AB. 2018. Tolerability and efficacy of a
medical device repairing emollient cream in
adults with chronic hand dermatitis. J
Cosmet Dermatol, 17: 1158-1164.
Toklu HZ, Tunalı-Akbay T, Erkanl G, Yuksel
M, Ercan F, Sener G. 2007. Silymarin, the
antioxidant component of Silybum
marianum, protects against burn-induced
oxidative skin injury. Burns, 33: 908-916.
Vafaei-Nodeh S, Kabiri-Abyaneh S. 2020.
Long-term control of atopic dermatitis with
platelet-rich plasma. JAAD Case Rep, 7: 54-
Vargas-Mendoza N, Angeles-Valencia M,
Morales-González Á, Morales-Martínez M,
Madrigal-Bujaidar E, Álvarez-González I,
Fregoso-Aguilar T, Delgado-Olivares L,
Madrigal-Santillán EO, Morales-González
JA. 2020. Effect of silymarin
supplementation on physical performance,
muscle and myocardium histological
changes, bodyweight, and food
consumption in rats subjected to regular
exercise training. Int J Mol Sci, 21: 7724.
Vrba J, Papoušková B, Kosina P, Lněničková
K, Valentová K, Ulrichová J. 2020.
Identification of human sulfotransferases
active towards silymarin flavonolignans and
taxifolin. Metabolites, 10: 329.
Zhao J, Lahiri-Chatterjee M, Sharma Y,
Agarwal R. 2000. Inhibitory effect of a
flavonoid antioxidant silymarin on benzoyl
peroxide-induced tumor promotion,
oxidative stress and inflammatory responses
in SENCAR mouse skin. Carcinogenesis,
21: 811-816.